| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |